SCHEMBL17827042

SCHEMBL17827042

COc1ccc(-c2cc(N)nc3c(Cl)cccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 1/20 0.47
AURKA O14965 1/20 0.45
AURKB Q96GD4 1/20 0.45
DYRK1A Q13627 3/20 0.44
NR4A2 P43354 1/20 0.44
ENPP1 P22413 2/20 0.44
ENPP3 O14638 1/20 0.44
APP P05067 1/20 0.43
BACE1 P56817 1/20 0.43
MAPT P10636 3/20 0.43
HRH4 Q9H3N8 1/20 0.42
CRHR1 P34998 1/20 0.41
ADORA2A P29274 1/20 0.41
NT5E P21589 1/20 0.40
SYK P43405 1/20 0.40
NUDT1 P36639 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8136665 0.86 ACACA (0.49) ACACAAURKAAURKBDYRK1ANR4A2
SCHEMBL4659565 0.84 NR4A2 (0.46) DYRK1ANR4A2APPBACE1MAPT
SCHEMBL4657240 0.83 NR4A2 (0.47) AURKBNR4A2ENPP1BACE1MAPT
SCHEMBL1592921 0.74 XPO1 (0.54) ACACAAURKAAURKBDYRK1AENPP1
SCHEMBL29934212 0.74 XPO1 (0.54) ACACAAURKAAURKBDYRK1AENPP1
SCHEMBL1592924 0.73 DYRK1A (0.38) ACACAAURKAAURKBDYRK1AENPP1
SCHEMBL13906866 0.72 NR4A2 (0.56) AURKADYRK1ANR4A2MAPTCRHR1
SCHEMBL7708814 0.70 DYRK1A (0.65) DYRK1AAPPMAPT
SCHEMBL4013124 0.70 NR4A2 (0.51) NR4A2MAPTCRHR1KMT2A
SCHEMBL27971605 0.70 MCHR1 (0.57) DYRK1AENPP1APPBACE1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088397-A1 COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER Canbas Co. Ltd. (JP) 2016-11-02 EP disclosed
EP-2152692-B1 COMPOUNDS WITH ANTI-CANCER ACTIVITY CANBAS CO LTD (JP) 2016-06-15 EP disclosed